Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir
Patients who discontinue tenofovir alafenamide (TAF) therapy appear to have a higher hepatitis B virus relapse rate than those who ceased entecavir or tenofovir disoproxil fumarate (TDF) therapy, according to a recent study.
Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir
04 Dec 2025